• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Gregory T. Went

edit

Gregory Went (Ph.D.) is the Board Member at Tethys Bioscience.

He is currently the Chief Executive Officer & Chairman at Adamas Pharmaceuticals. Dr. Went, founding CEO and Chairman of Adamas Pharmaceuticals, has overseen the development of the company since its inception.

Previously, Dr. Went Co - Founded CuraGen Corporation in 1992, where he served as an Executive Vice President and Director.

Dr. Went serves on the Board of Directors of,

Tethys Bioscience,

Angelica Therapeutics.

He is a Managing Director of Halteres Associates.

Dr. Went received his Ph.D. in Chemical Engineering from the University of California, Berkeley, and is the author of 20 papers and an inventor on more than 45 patents and patent applications.

Recent Milestones

edit

• 
  Gregory T. Went added a position as Co - Founder / Executive Vice President / Director at Curagen Corporation. (1/1/92)
  Posted 5/6/13 at 1:39pm
• 
  Gregory T. Went added a position as Managing Director at Halteres Associates.
  Posted 5/6/13 at 1:39pm
• 
  Gregory T. Went added a position as Board Member at Angelica Therapeutics.
  Posted 5/6/13 at 1:39pm
• 
  Gregory T. Went added a position as Board Member at Tethys BioScience.
  Posted 5/6/13 at 1:24pm
• 
  Gregory T. Went added a position as Chief Executive Officer & Chairman at Adamas Pharmaceuticals.
  Posted 10/21/09 at 11:04pm

Videos

Sources